771 related articles for article (PubMed ID: 22817125)
1. High correlation between clearance of renal protein-bound uremic toxins (indoxyl sulfate and p-cresyl sulfate) and renal water-soluble toxins in peritoneal dialysis patients.
Huang WH; Hung CC; Yang CW; Huang JY
Ther Apher Dial; 2012 Aug; 16(4):361-7. PubMed ID: 22817125
[TBL] [Abstract][Full Text] [Related]
2. Time profiles of peritoneal and renal clearances of different uremic solutes in incident peritoneal dialysis patients.
Bammens B; Evenepoel P; Verbeke K; Vanrenterghem Y
Am J Kidney Dis; 2005 Sep; 46(3):512-9. PubMed ID: 16129214
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of p-cresyl sulfate and indoxyl sulfate, but not inflammatory markers, increase in incident peritoneal dialysis patients in parallel with loss of residual renal function.
Viaene L; Meijers BK; Bammens B; Vanrenterghem Y; Evenepoel P
Perit Dial Int; 2014; 34(1):71-8. PubMed ID: 24179107
[TBL] [Abstract][Full Text] [Related]
4. Removal of Different Classes of Uremic Toxins in APD vs CAPD: A Randomized Cross-Over Study.
Eloot S; Vanholder R; Dequidt C; Van Biesen W
Perit Dial Int; 2015; 35(4):436-42. PubMed ID: 24584609
[TBL] [Abstract][Full Text] [Related]
5. Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration.
Krieter DH; Hackl A; Rodriguez A; Chenine L; Moragues HL; Lemke HD; Wanner C; Canaud B
Nephrol Dial Transplant; 2010 Jan; 25(1):212-8. PubMed ID: 19755476
[TBL] [Abstract][Full Text] [Related]
6. Superior dialytic clearance of beta(2)-microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis.
Evenepoel P; Bammens B; Verbeke K; Vanrenterghem Y
Kidney Int; 2006 Aug; 70(4):794-9. PubMed ID: 16820785
[TBL] [Abstract][Full Text] [Related]
7. Peritoneal phosphate removal varies by peritoneal dialysis regimen: an underestimated parameter of phosphate control.
Botelho C; Rodrigues A; Oliveira JC; Cabrita A
J Nephrol; 2013; 26(1):183-90. PubMed ID: 22460184
[TBL] [Abstract][Full Text] [Related]
8. Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms.
Bammens B; Evenepoel P; Verbeke K; Vanrenterghem Y
Kidney Int; 2003 Dec; 64(6):2238-43. PubMed ID: 14633148
[TBL] [Abstract][Full Text] [Related]
9. Removal of the protein-bound solutes indican and p-cresol sulfate by peritoneal dialysis.
Pham NM; Recht NS; Hostetter TH; Meyer TW
Clin J Am Soc Nephrol; 2008 Jan; 3(1):85-90. PubMed ID: 18045861
[TBL] [Abstract][Full Text] [Related]
10. Reduction in protein-bound solutes unacceptable as marker of dialysis efficacy during alternate-night nocturnal hemodialysis.
Meijers B; Toussaint ND; Meyer T; Bammens B; Verbeke K; Vanrenterghem Y; Kerr PG; Evenepoel P
Am J Nephrol; 2011; 34(3):226-32. PubMed ID: 21791919
[TBL] [Abstract][Full Text] [Related]
11. Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor.
Madero M; Cano KB; Campos I; Tao X; Maheshwari V; Brown J; Cornejo B; Handelman G; Thijssen S; Kotanko P
Clin J Am Soc Nephrol; 2019 Mar; 14(3):394-402. PubMed ID: 30755453
[TBL] [Abstract][Full Text] [Related]
12. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study.
Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA
Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329
[TBL] [Abstract][Full Text] [Related]
13. Relationship of serum cystatin C to peritoneal and renal clearance measures in peritoneal dialysis: a cross-sectional study.
Delaney MP; Stevens PE; Al Hasani M; Stowe HJ; Judge C; Lamb EJ
Am J Kidney Dis; 2008 Feb; 51(2):278-84. PubMed ID: 18215705
[TBL] [Abstract][Full Text] [Related]
14. Clearance of p-cresol sulfate and β-2-microglobulin from dialysate by commercially available sorbent technology.
Kruse A; Tao X; Bhalani V; Handelman G; Levin NW; Kotanko P; Thijssen S
ASAIO J; 2011; 57(3):219-24. PubMed ID: 21499073
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with blood concentrations of indoxyl sulfate and p-cresol in patients undergoing peritoneal dialysis.
Lee CT; Kuo CC; Chen YM; Hsu CY; Lee WC; Tsai YC; Ng HY; Kuo LC; Chiou TT; Yang YK; Cheng BC; Chen JB
Perit Dial Int; 2010; 30(4):456-63. PubMed ID: 20338972
[TBL] [Abstract][Full Text] [Related]
16. The relationship between Kt/V(urea) and nPNA in anuric peritoneal dialysis patients: a comparison with predialysis patients.
Jansen MA; Korevaar JC; Dekker FW; Jager KJ; Boeschoten EW; Krediet RT;
Perit Dial Int; 2001; 21(5):509-15. PubMed ID: 11757836
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of body size indices, residual renal function, and peritoneal transport characteristics in continuous ambulatory peritoneal dialysis.
Twardowski ZJ; Moore HL; Prowant BF; Satalowich R
Adv Perit Dial; 2009; 25():155-64. PubMed ID: 19886338
[TBL] [Abstract][Full Text] [Related]
18. Interaction between two sulfate-conjugated uremic toxins, p-cresyl sulfate and indoxyl sulfate, during binding with human serum albumin.
Watanabe H; Noguchi T; Miyamoto Y; Kadowaki D; Kotani S; Nakajima M; Miyamura S; Ishima Y; Otagiri M; Maruyama T
Drug Metab Dispos; 2012 Jul; 40(7):1423-8. PubMed ID: 22513409
[TBL] [Abstract][Full Text] [Related]
19. The effect of peritoneal dialysis method on residual renal function in children.
Roszkowska-Blaim M; Skrzypczyk P; Jander A; Tkaczyk M; Bałasz-Chmielewska I; Zurowska A; Drozdz D; Pietrzyk JA
Adv Perit Dial; 2012; 28():112-9. PubMed ID: 23311226
[TBL] [Abstract][Full Text] [Related]
20. Adequacy of dialysis in automated peritoneal dialysis: a clinical experience.
Fernández Rodríguez AM; Vega Díaz N; Palop Cubillo L; Baamonde Laborda E; Morales Umpierrez A; Pérez Borges P; Navarro Zurita M; Plaza Toledano C
Perit Dial Int; 1997; 17(5):442-8. PubMed ID: 9358525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
